Please log in to view this page
Username
Password
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
